Adjuvant Radiotherapy After Modified Ivor-Lewis Esophagectomy: Can It Prevent Lymph Node Recurrence of the Mid-Thoracic Esophageal Carcinoma?

Annals of Thoracic Surgery

Volumn 87, Issue 6, 2009, Pages 1697-1702

  Chen, Gang ^a   Wang, Zhou ^a   Liu, Xiang yan ^a   Liu, Fan ying ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MODIFIED IVOR LEWIS ESOPHAGECTOMY; OVERALL SURVIVAL; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 65649131650     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.03.060     Document Type: Article

References (15)

1. Dresner S.M., and Griffin S.M. Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy. Br J Surg 87 (2000) 1426-1433
2. Chen G., Wang Z., Liu X.Y., and Liu F.Y. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy. World J Surg 31 (2007) 1107-1114
3. Korst R.J., Rusch V.W., Venkatraman E., et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 115 (1998) 660-669
4. Udagawa H., and Akiyama H. Surgical treatment of esophageal cancer: Tokyo experience of the three-field technique. Dis Esophagus 14 (2001) 110-114
5. Law S., and Wong J. Two-field dissection is enough for esophageal cancer. Dis Esophagus 14 (2001) 98-103
6. Visbal A.L., Allen M.S., Miller D.L., Deschamps C., Trastek V.F., and Pairolero P.C. Ivor Lewis esophagogastrectomy for esophageal cancer. Ann Thorac Surg 71 (2001) 1803-1808
7. Fujita H., Kakegawa T., Yamana H., et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 222 (1995) 654-662
8. Griffin S.M., Shaw I.H., and Dresner S.M. Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy: risk factors and management. J Am Coll Surg 194 (2002) 285-297
9. Chen G., Wang Z., Liu X.Y., Zhang M.Y., and Liu F.Y. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus. Eur J Cardiothorac Surg 35 (2009) 1-7
10. Nakagawa S., Kanda T., Kosugi S., Ohashi M., Suzuki T., and Hatakeyama K. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg 198 (2004) 205-211
11. Bhansali M.S., Fujita H., Kakegawa T., et al. Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg 21 (1997) 275-281
12. Yamamoto M., Yamashita T., Matsubara T., et al. Reevaluation of postoperative radiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 37 (1997) 75-78
13. Ando N., Iizuka T., Ide H., et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. Clin Oncol 21 (2003) 4592-4596
14. Vazquez-Sequeiros E., Wang L., Burgart L., et al. Occult lymph node metastases as a predictor of tumor relapse in patients with node-negative esophageal carcinoma. Gastroenterology 122 (2002) 1815-1821
15. Li S.H., Wang Z., Liu X.Y., Liu F.Y., Sun Z.Y., and Xue H. Lymph node micrometastasis: a predictor of early tumor relapse after complete resection of histologically node-negative esophageal cancer. Surg Today 37 (2007) 1047-1052